Evaluation report of a social prescribing scheme led by Gloucestershire clinical commissioning group, which focuses on its impact and value, and explores return on investment.
Abstract: There are increasing numbers of people presenting to GP practices. In 1995 patients visited GPs on average 3.9x a year; this had increased to 5.5x a year in 2012. GP attendances have climbed from 17.8m in 2004-5 to 24m in 2012-13 (Campbell 2013:4). The DoH and NHS England have not routinely collected data on activity levels in general practice since 2008-09; but modelling attendance data from 2009 means that it is believed that there were 37m GP consultations in England in 2014-15 (National Audit Office, 2015).The Social Prescribing Network (SPN) have reviewed over 400 different social prescribing projects (Polley, 2016). In their presentation to the Health Select Committee in March 2016 they revealed that 49% of these projects were identified has having some CCG financial involvement. Of which 14% were CCG and public health/local authority partnerships. Sole CCG funded social prescribing projects can be found within and across: Wakefield, Hertfordshire, Rotherham, Bradford, Lewisham, Hackney and City, Bradford, Camden and Sheffield CCGs. Gloucestershire CCG’s social prescribing service reflects a growing trend around the country of local health professionals developing local, organic, initiatives to manage the increase in demand for primary care services. This report outlines the impact and value of the social prescribing service in Gloucestershire. It suggests a return on investment to health services will be found in the medium turn